Q4 2024 Holdings
Filed 2025-02-14 | 33 holdings | $607.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $96.0M | 3,006,980 | 15.8% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $54.9M | 2,059,387 | 9.0% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $46.0M | 2,110,167 | 7.6% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $33.4M | 1,993,052 | 5.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $26.5M | 571,264 | 4.4% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $24.5M | 9,202,907 | 4.0% |
| Insmed Inc(INSM) | COM PAR | 457669307 | $22.9M | 332,000 | 3.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $21.6M | 2,763,000 | 3.5% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $21.1M | 488,000 | 3.5% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $21.0M | 3,018,000 | 3.5% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $20.7M | 2,425,000 | 3.4% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $18.1M | 10,450,000 | 3.0% |
| Insmed Inc(INSM)Call | COM PAR | 457669307 | $17.3M | 250,000 | 2.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $16.7M | 870,000 | 2.7% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $16.6M | 18,350,000 | 2.7% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $15.7M | 668,000 | 2.6% |
| Pharvaris N V(PHVS) | COM | N69605108 | $14.9M | 778,000 | 2.5% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $13.2M | 1,115,000 | 2.2% |
| Merus N V | COM | N5749R100 | $13.0M | 308,000 | 2.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $12.9M | 5,136,795 | 2.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $12.1M | 441,600 | 2.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $12.0M | 904,000 | 2.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $11.6M | 1,370,000 | 1.9% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $7.9M | 10,000,000 | 1.3% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $7.7M | 4,848,802 | 1.3% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $7.4M | 2,304,752 | 1.2% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $6.9M | 303,000 | 1.1% |
| Allovir Inc | COM | 019818202 | $4.7M | 11,215,000 | 0.8% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $3.3M | 900,000 | 0.5% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $2.6M | 250,000 | 0.4% |
| Centessa Pharmaceuticals PLC(CNTA)Put | SPONSORED ADS | 152309100 | $2.5M | 152,000 | 0.4% |
| Mersana Therapeutics Inc | COM | 59045L106 | $1.4M | 992,000 | 0.2% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 02/10/202 | 67080N119 | $830.8K | 312,336 | 0.1% |